Joy PXF Capsule contains Polmacoxib 2mg, a selective cyclooxygenase-2 (COX-2) inhibitor used primarily for the management of pain and inflammation associated with osteoarthritis and rheumatoid arthritis. Polmacoxib exerts its therapeutic effects by selectively inhibiting the COX-2 enzyme, thereby reducing the synthesis of prostaglandins responsible for inflammation, pain, and swelling, while sparing COX-1, which helps minimize gastrointestinal adverse effects commonly seen with non-selective NSAIDs. Joy PXF Capsule is indicated for relief of symptoms such as joint pain, stiffness, and swelling, improving patient mobility and quality of life. It is generally well tolerated, but caution is advised in patients with a history of cardiovascular disease, gastrointestinal ulcers, or renal impairment. The recommended dosage should be adhered to strictly, and it is important to monitor for any signs of adverse reactions such as gastrointestinal discomfort, cardiovascular symptoms, or hypersensitivity. Polmacoxib should be used at the lowest effective dose for the shortest duration necessary to control symptoms. Patients should consult their healthcare provider before initiating therapy, especially if they are pregnant, nursing, or taking concomitant medications that may interact with COX-2 inhibitors. Joy PXF Capsule offers an effective option for targeted anti-inflammatory therapy with a favorable safety profile compared to traditional NSAIDs.